Reckitt also announced that Serena Williams is named the company's first Entrepreneur-in-Residence and will play a key role in mentoring and supporting women leading these ventures.

By Amy-Jo Crowley and Richa Naidu LONDON (Reuters) -Britain’s Reckitt is considering new options to advance a sale of its Essential Home business, home to Air Wick fresheners and Cillit Bang ...

Reckitt Benckiser’s stable yield and restructuring plans offer downside protection amid mixed Q1 results. Find out why RBGPF stock is a hold.

The consumer goods group Reckitt’s plan to sell off a portfolio of cleaning products including Air Wick to private equity is at risk of falling through amid the recent bout of market turmoil ...

Reckitt shares were down by more than 4.5% in morning trade. The company's first-quarter like-for-like net sales rose 1.1%, below the 1.4% analysts had expected in a company-supplied poll.

Reckitt cautions over possible delay to sale of Cillit Bang arm amid market woes Reckitt said it was still aiming to sell the division this year, but admitted ‘market conditions may impact this ...

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies. A jury in October found the companies not ...

Abbott was down 2.7% at 1:54 p.m. in New York after paring morning losses, while Reckitt’s shares fell as much as 5.6% in London before closing down 1.7%. Both early declines were the biggest in ...

Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as “non-core” in July as part of a ...

Reckitt is investing £155 million ($200 million) in the site to establish a state-of-the-art manufacturing facility, which will ensure a more resilient supply chain in its largest market.

Over-the-counter drug giant Reckitt shelled out $200 million for a site to expand its manufacturing facility in North Carolina where it produces the popular cold and flu drug Mucinex.

The ruling by a Missouri state court jury Thursday is a rare legal win for Abbott Laboratories, maker of the Similac formula, and Reckitt, which produces the Mead Johnson formula, following their ...